| ||
| ImmunoGen, Inc. Announces First Data for its Novel Therapeutic for Ovarian ... PharmiWeb.com (press release) IMGN853 is designed to selectively target and kill cancer cells expressing folate receptor 1 (FOLR1). This target is over-expressed on most cases of ovarian cancer as well as on other carcinomas including types of non-small cell lung cancers. ... See all stories on this topic » |
| ||
| Small Cell Lung Cancer Questionnaire - Alliance Hematology ... Lung cancer is classified into two major categories of small cell lung cancer ( SCLC) and non-small cell lung cancer (NSCLC). Approximately 13% of newly ... https://www.treatmentoptions.usoncology.com/.../CancerThera... |
This once a day Google Alert is brought to you by Google.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment